Patent: 9,333,173
✉ Email this page to a colleague
Summary for Patent: 9,333,173
| Title: | Bioerodible silicon-based devices for delivery of therapeutic agents |
| Abstract: | This invention discloses bioerodible devices, such as implants for delivering therapeutic agents, particularly large molecules such as proteins and antibodies, in a controlled manner. The devices comprise a porous silicon-based carrier material impregnated with the therapeutic agent. The device may be used in vitro or in vivo to deliver the therapeutic agent, preferably in a controlled fashion over an intended period of time such as over multiple days, weeks or months. The device may be used for treating or preventing conditions of a patient such as chronic diseases. |
| Inventor(s): | Ashton; Paul (Newton, MA), Canham; Leigh T. (Malvern, GB), Barnett; Christian (Throckmorton, GB) |
| Assignee: | pSivida US, Inc. (Watertown, MA) |
| Application Number: | 13/286,788 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,333,173
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2030-11-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
